NatWest Markets Strategy & Sales

Western Europe Covid-19 Monitor
NWM Rates StrategyImogen Bachra, CFA
29 September 2021 16:07


Authors
Imogen Bachra, CFA
Head of Non-Dollar Rates Strategy
London
+44 20 7085 8381

Contributors
{{contributor-span-repeater}}

If you wish to discuss the content of this article further, please contact your usual sales person. Reminder, clients of Natwest Markets NV should reach out to their relevant NV sales person.

Western Europe Covid-19 Monitor

Cases and hospitalizations remain low (particularly in Europe). The return to school and the lightening up on some travel restrictions does not seem to have had a material impact. UK cases are still higher than in the rest of Europe, but hospitalisations and mortality rates are still low enough to allow the continued easing of restrictions.

Vaccinations remain the central focus of the efforts to ward off virus surge in the winters. Focus has shifted to booster programmes, which are now getting underway in the UK and many European countries.

Uncertainties remain high, particularly as we head into the colder winter months, but covid news is improving globally, for now. This is one of the factors that has helped markets to re-assess growth and inflation expectations over the past few weeks.

In this report:

Western Europe Overview........................................................................... (p2)

Testing and positivity rates.......................................................................... (p3)

Vaccine capacity and distribution by country............................................ (p4)

Vaccine distribution vs supply by country.................................................. (p5)

Daily vaccination rates................................................................................. (p7)

Vaccines by age group................................................................................. (p9)

(NEW) Case and mortality rates: wave two vs wave three...................... (p11)

Regional 7-day case rates per 100k population........................................ (p15)

Regional case numbers vs social distancing index heatmap................... (p17)

Maps of regional case numbers by GDP.................................................... (p18)

Regional hospitalisation rates...................................................................... (p20)

Excess mortality by country........................................................................ (p22)

  

  

  

  

  

  


Please click here to find all of NatWest Markets’ Strategy and Sales commentary/ideas. 

You can also find out more about our electronic offering and credentials for Rates here and for FX here.


This is Non-Independent Research, as defined by the Financial Conduct Authority. Not intended for Retail Client distribution. This material should be regarded as a marketing communication and may have been produced in conjunction with the NatWest Markets Plc trading desks that trade as principal in the instruments mentioned herein. All data is accurate as of the report date, unless otherwise specified.

This communication has been prepared by NatWest Markets Plc, and should be regarded as a Marketing Communication, for which the relevant competent authority is the UK Financial Conduct Authority.

Please follow the link for the following information https://ci.natwest.com/regulatory-information/market-abuse-regulation-mar-disclosures:

  • MAR Disclaimer
  • Conflicts of Interest statement
  • Glossary of definitions
  • Historic Trade ideas log

All data is accurate as of the report date, unless otherwise specified.

 

This communication has been prepared by NatWest Markets Plc, NatWest Markets N.V. (and/or any branches) or an affiliated entity (“NatWest Markets”), and should be regarded as a Marketing Communication, for which the relevant competent authority is the UK Financial Conduct Authority (for NatWest Markets Plc) and the Autoriteit FinanciĆ«le Markten (for NatWest Markets N.V.).

 

Please follow the link for the following information https://www.natwest.com/corporates/support/regulatory-information/market-abuse-regulation-mar-disclosures.html:

 

MAR Disclaimer

Conflicts of Interest statement

Glossary of definitions

Historic Trade ideas log

 

This material is a Marketing Communication and has not been prepared in accordance with the legal and regulatory requirements designed to promote the independence of investment research and may have been produced in conjunction with the NatWest Markets trading desks that trade as principal in the instruments mentioned herein. This commentary is therefore not independent from the proprietary interests of NatWest Markets, which may conflict with your interests. Opinions expressed may differ from the opinions expressed by other business units of NatWest Markets. The remuneration of the author(s) is not directly tied to any transactions performed, or trading fees received, by any entity of the NatWest Group, for example, through the use of commission-based remuneration.

 

This material includes references to securities and related derivatives that the firm's trading desk may make a market or provide liquidity in, and in which it is likely as principal to have a long or short position at any time, including possibly a position that was accumulated on the basis of this analysis material prior to its dissemination. Trading desks may also have or take positions inconsistent with this material. This material may have been made available to other clients of NatWest Markets before it has been made available to you and is not subject to any prohibition on dealing ahead of its dissemination. This document has been prepared for information purposes only, does not constitute an analysis of all potentially material issues and is subject to change at any time without prior notice. NatWest Markets does not undertake to update you of such changes. It is indicative only and is not binding. Other than as indicated, this document has been prepared on the basis of publicly available information believed to be reliable but no representation, warranty, undertaking or assurance of any kind, express or implied, is made as to the adequacy, accuracy, completeness or reasonableness of this material, nor does NatWest Markets accept any obligation to any recipient to update, correct or determine the reasonableness of such material or assumptions contained herein. NatWest Markets and each of its respective affiliates accepts no liability whatsoever for any direct, indirect or consequential losses (in contract, tort or otherwise) arising from the use of this material or reliance on the information contained herein. However this shall not restrict, exclude or limit any duty or liability to any person under any applicable laws or regulations of any jurisdiction which may not lawfully be disclaimed. The opinions, commentaries, projections, forecasts, assumptions, estimates, derived valuations and target price(s) or other statements contained in this communication (the “Views”) are valid as at the indicated date and/or time and are subject to change at any time without prior notice. NatWest Markets does not undertake to update you of such changes. Views expressed herein are not intended to be, and should not be viewed as advice or as a personal recommendation. The Views may not be objective or independent of the interests of the authors or other NatWest Markets trading desks, who may be active participants in the markets, investments or strategies referred to in this material. NatWest Markets will not act and has not acted as your legal, tax, regulatory, accounting or investment adviser; nor does NatWest Markets owe any fiduciary duties to you in connection with this and/or any related transaction and no reliance may be placed on NatWest Markets for investment advice or recommendations of any sort. You should make your own independent evaluation of the relevance and adequacy of the information contained in this document and make such other investigations as you deem necessary, including obtaining independent financial advice, before participating in any transaction in respect of the securities referred to in this document. This document is not intended for distribution to, or use by any person or entity in any jurisdiction or country where such distribution or use would be contrary to local law or regulation. The information contained herein is proprietary to NatWest Markets and is being provided to selected recipients and may not be given (in whole or in part) or otherwise distributed to any other third party without the prior written consent of NatWest Markets.

 

NatWest Markets and its respective affiliates, connected companies, employees or clients may have an interest in financial instruments of the type described in this document and/or in related financial instruments giving rise to potential conflicts of interest which may impact the performance of such financial instruments. Such interests may include, but are not limited to, (a) dealing in, trading, holding or acting as market-maker or liquidity provider in such financial instruments and any reference obligations; (b) entering into hedging strategies on behalf of issuer clients and their affiliates, investor clients or for itself or its affiliates and connected companies; and (c) providing banking, credit and other financial services to any company or issuer of securities or financial instruments referred to herein. NatWest Markets and its affiliates, connected companies, employees or clients may at any time acquire, hold or dispose or long or short positions (including hedging and trading positions) which may impact the performance of a financial instrument.

 

In the U.S., this Marketing Communication is intended for distribution only to major institutional investors as defined in Rule 15a-6 of the U.S. Securities Exchange Act 1934 (excluding documents produced by our affiliates within the U.S. which are subject to the following disclaimer https://www.agilemarkets.com/api/ds/v1/disclaimer/publication/2756 ). Any U.S. recipient wanting further information or to effect any transaction related to this trade idea must contact NatWest Markets Securities Inc., 600 Washington Boulevard, Stamford, CT, USA. Telephone: +1 203 897 2700.

 

Where communicated in Singapore, this communication may be deemed an advertisement. This advertisement has not been reviewed by the Monetary Authority of Singapore.

 

NatWest Markets Plc is authorised by the Prudential Regulation Authority and regulated by the Financial Conduct Authority and Prudential Regulation Authority and is provisionally registered as a swap dealer with the United States Commodity Futures Commission. NatWest Markets N.V. is incorporated with limited liability in the Netherlands, authorised by De Nederlandsche Bank and regulated by De Nederlandsche Bank and the Autoriteit Financiële Markten. It has its seat at Amsterdam, the Netherlands, and is registered in the Commercial Register under number 33002587. Registered Office: Claude Debussylaan 94, Amsterdam, The Netherlands. Branch Reg No. in England BR001029. Agency agreements exist between different members of NatWest Group. Securities business in the United States is conducted through NatWest Markets Securities Inc., a FINRA registered broker-dealer ( http://www.finra.org ), a SIPC member ( www.sipc.org ) and a wholly owned indirect subsidiary of NatWest Markets Plc. NatWest Markets Securities Inc. is authorised by NatWest Markets Plc to act as its agent for certain kinds of its activities.

 

For further information relating to materials provided by NatWest Markets, please view our Agile Markets Terms and Conditions

 

Copyright © NatWest Markets Plc. All rights reserved.